doxiproct
omedicamed, unipessoal lda, portugalsko - lidokaín - 23 - antihaemorrhoidalia
doxiproct plus
omedicamed, unipessoal lda, portugalsko - dexametazón - 23 - antihaemorrhoidalia
strepsils plus
reckitt benckiser (czech republic), spol. s r.o. , Česká republika - rôzne - 69 - otorhinolaryngologica
true test 24
smartpractice denmark aps, dánsko - testy na alergické choroby - 48 - diagnostica
true test 36
smartpractice denmark aps, dánsko - testy na alergické choroby - 48 - diagnostica
5-fluorouracil ,,ebewe" 500 mg
sandoz pharmaceuticals d.d. - fluóruracil - 44 - cytostatica
micetal gél
j. uriach y compaňía, s.a., Španielsko - flutrimazol - 26 - antimycotica (lokÁlne a celkovÉ)
imfinzi
astrazeneca ab - durvalumab - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
voltaren 1x denne 140 mg liečivá náplasť
haleon czech republic s.r.o., Česká republika - diklofenak - 29 - antirheumatica, antiphlogistica, antiuratica
zolvix
elanco gmbh - monepantel - anthelmintics, - ovce - zolvix ústne riešenie je široké spektrum antihelmintikám pre liečbu a kontrolu gastrointestinálne borovicové infekcie a pridružených ochorení v oviec vrátane jahniat, hoggets, plemenné barany a ovce. spectrum of activity includes fourth larvae and adults of: , haemonchus contortus*;, teladorsagia circumcincta*;, teladorsagia trifurcata*;, teladorsagia davtiani*;, trichostrongylus axei*;, trichostrongylus colubriformis;, trichostrongylus vitrinus;, cooperia curticei;, cooperia oncophora;, nematodirus battus;, nematodirus filicollis;, nematodirus spathiger;, chabertia ovina;, oesophagostomum venulosum. , * vrátane potlačený lariev. veterinárny liek je účinný proti kmene týchto parazitov, odolné voči (pro)benzimidazoles, levamizol, morantel, macrocyclic laktónov a h. contortus kmeňov odolných voči salicylanilidom.